Neurostimulation to Treat Refractory Angina Pectoris Pain (STARTSTIM)
STARTSTIM - Stimulation Therapy for Angina Refractory To Standard Treatments, Interventions and Medications
Sponsor: MedtronicNeuro
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from MedtronicNeuro
Other Angina Pectoris trials with similar outcome
This PHASE3 trial investigates Angina Pectoris and is currently terminated or withdrawn. MedtronicNeuro leads this study, which shows 6 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Dec 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MedtronicNeuro
For direct contact, visit the study record on ClinicalTrials.gov .